Literature DB >> 7674898

BSH distributions in the canine head and a human patient using 11B MRI.

K M Bradshaw1, M P Schweizer, G H Glover, J R Hadley, R Tippets, P P Tang, W L Davis, M P Heilbrun, S Johnson, T Ghanem.   

Abstract

A 3D projection reconstruction (3DPR) method was used to obtain in vivo 11B images in a large canine brain tumor model and in a human infused with borocaptate sodium (BSH). Studies were performed in dogs with and without gliosarcomas implanted and grown to a size of 2-3 cm. The 3DPR method demonstrates a signal-to-noise ratio (SNR) that allows qualitative kinetic studies of the boron compound in normal and tumor tissue of the head. The measurements indicate initial uptake of the BSH compound in tumor to be less than that in muscle with no uptake in normal brain tissue. Moreover, uptake of BSH in tissue was found to lag the boron concentration in blood with delays that depend on tissue type. In addition, the first human boron images were obtained on a patient who underwent surgical resection and volumetric debulking of a large (7 cm) glioblastoma multiforme. BSH was readily taken up in residual tumor tissue, while diffusion into the resection volume was slower.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7674898     DOI: 10.1002/mrm.1910340109

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  2 in total

1.  Boron neutron capture therapy. Clinical brain tumor studies.

Authors:  Y Nakagawa; H Hatanaka
Journal:  J Neurooncol       Date:  1997-05       Impact factor: 4.130

2.  The role of boron MRI in boron neutron capture therapy.

Authors:  G W Kabalka; C Tang; P Bendel
Journal:  J Neurooncol       Date:  1997-05       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.